Showing results (531-540 of 611) with videos related to
Sort By:
Pageof 62
European Journal of Medicinal Chemistry|November 15, 2025
2-amido-3-aryl-4-methyl-thiazole derivatives as broad-spectrum anti-rhinoviral agentsSileshi Abera Ayele, Hye Lim Lee, Céline Sablon, et al.Science Advances|October 3, 2025
1'-Cyanocytidine-5'-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamstersFranck Amblard, Mahesh Kasthuri, Julia C LeCher, et al.Nature Communications|October 30, 2021
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the hostVerónica Lloréns-Rico, Ann C Gregory, Johan Van Weyenbergh, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2008
A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004Louisa E Chapman, John K Iskander, Robert T Chen, et al.The Journal of Infectious Diseases|May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United StatesAudrey Godin, Ruth I Connor, Hanna N Degefu, et al.Antiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.Antimicrobial Agents and Chemotherapy|July 31, 2013
A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβHilde M van der Schaar, Pieter Leyssen, Hendrik J Thibaut, et al.Microbiology Spectrum|June 7, 2022
A High-Throughput Yellow Fever Neutralization AssayMadina Rasulova, Thomas Vercruysse, Jasmine Paulissen, et al.Journal of Virology|December 15, 2005
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymeraseJan Paeshuyse, Pieter Leyssen, Eric Mabery, et al.Journal of Medicinal Chemistry|March 14, 2024
Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B InhibitorBart Kesteleyn, Jean-François Bonfanti, Dorothée Bardiot, et al.Pageof 62